Skip to search formSkip to main contentSkip to account menu

YM 53601

Known as: (E)-2-(2-fluoro-2-(quinuclidin-3-ylidene)ethoxy)-9H-carbazole monohydrochloride, YM-53601, YM53601 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Quinuclidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Analysis of Bioactive Components of Dr.M.-Healing®As a Mixed Herbal Product
The food supplements which are made from plant products have been used throughout human history for various purposes. Still, many… 
2008
2008
Papel del colesterol mitocondrial en la resistencia del carcinoma hepatocelular a la quimioterapia
DE LA TESIS:Distintas evidencias en la bibliografia apuntan al colesterol como uno de los componentes lipidicos celulares cuyos… 
2003
2003
YM‐53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents
To better understand how it decreases plasma cholesterol and triglyceride levels, we evaluated the effect of (E)‐2‐[2‐fluoro‐2… 
2003
2003
Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.
2002
2002
Experimental model of escape phenomenon in hamsters and the effectiveness of YM‐53601 in the model
The aim of this study was to establish an experimental model of the escape phenomenon, in which plasma cholesterol, initially… 
2002
2002
Effect of YM‐53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters
To better understand how it decreases plasma cholesterol and triglyceride, we evaluated the effect of YM‐53601 ((E‐2‐[2‐fluoro‐2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)